Microvascular Angina (Cardiac Syndrome X)

Angina with Normal Coronary Arteries

coloroftime/E+/Getty Images

Cardiac Syndrome X, or microvascular angina, is diagnosed when a person has angina, with evidence of cardiac ischemia on stress testing, but with normal-looking coronary arteries on cardiac catheterization. In most cases, microvascular angina is caused by a disorder of the small branches of the coronary arteries in which these tiny vessels fail to dilate normally, thus producing a lack of blood flow to the heart muscle.

Since the problem is now thought to be localized to the small arteries, the older name of cardiac syndrome X has largely been supplanted by the more descriptive term, microvascular angina. Notably, however, some experts believe that people with this condition may instead have an abnormal sensitivity to cardiac muscle pain.

Microvascular angina is much more common in women (typically, postmenopausal women) than in men. There are several possible causes of the small artery dysfunction that is thought to be present in microvascular angina, including insulin resistance, inflammation, increased adrenalin activity, estrogen deficiency, and dysautonomia. It is likely that different patients with microvascular angina may have different underlying causes.

While most people with microvascular angina have a favorable prognosis — in that the risk of acute coronary syndromecaused by microvascular angina is quite low — it is not uncommon for the chest pain produced by this condition to be a significant, and sometimes disabling, problem.

Treating Microvascular Angina

Whenever you see a long list of possible treatments for some medical condition, it’s a sign that treating that condition may be difficult. (Likely, that’s why so many treatments have been tried in the first place.) Such is the case with microvascular angina.

Many medications have been found helpful in at least some patients with microvascular angina.

However, in finding the “best” treatment for any given individual, a trial-and-error approach is often required. This means that the both sufferer of microvascular angina and the doctor may need to be patient and persistent in order to find the optimal therapy.

Here is a list of treatments often used in treating microvascular angina:

Traditional Angina Drugs -

Non-traditional Angina Drugs -

  • Ranolazine — quite effective in small clinical trials
  • ACE inhibitors — especially in patients with hypertension
  • Ivabradine — also effective in small clinical trials
  • Statins — especially in patients with high cholesterol levels
  • Estrogens — in post-menopausal women
  • Imipramine — not an angina drug, but can be effective with pain control
  • l-arginine — may help to restore normal dilation of small blood vessels
  • Sildenafil (Viagra) — not well studied for microvascular angina, but may be quite effective in some people
  • Metformin — support for this drug in treating microvascular angina is purely anecdotal, and is not confirmed by clinical data.

Non-Drug Therapy -

  • EECP - shown in one small study to be effective for microvascular angina
  • Spinal cord stimulation - shown to be helpful in some patients in whom drug treatment has failed.
  • Exercise training has been quite helpful, especially in patients who are deconditioned.

A General Approach to the Treatment of Microvascular Angina

Given all these possibilities, most cardiologists will attempt to optimize the treatment of microvascular angina using a step-wise approach. If adequate control of symptoms is not obtained with any given step, the doctor and patient will move on to the next step.

  • Step 1 is usually to use sublingual nitroglycerin to relieve symptoms whenever they occur. A program of physical training is often strongly recommended as part of a first step as well. If this step does not provide sufficient relief:
  • Step 2 is usually to add a beta blocker. 
  • Step 3 is usually to stop the beta blocker, and substitute a calcium channel blocker.
  • Step 4 is usually to try ranolazine, either alone or with a beta blocker or calcium blocker.
  • Step 5 is to consider other drugs, or to add non-drug therapy, with spinal cord stimulation or EECP.

In addition to taking steps like these, an ACE inhibitor also should be strongly considered if hypertension is present, and a statin should be strongly considered if risk factors for typical coronary artery disease are also present. In women who are recently menopausal, estrogen therapy might be worth considering as well. 

With patience — perhaps a good deal of patience — adequate control of symptoms eventually can be achieved in the large majority of people who have microvascular angina. And while progressing through these steps, people with microvascular angina should keep in mind that their long-term prognosis is generally very good.


Camici PG, Crea F. Coronary Microvascular Dysfunction. N Engl J Med 2007; 356:830.

Eriksson BE, Tyni-Lennè R, Svedenhag J, et al. Physical Training in Syndrome X: Physical Training Counteracts Deconditioning and Pain in Syndrome X. J Am Coll Cardiol 2000; 36:1619.

Kaski JC. Pathophysiology and Management of Patients with Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X). Circulation 2004; 109:568.

Mehta PK, Goykhman P, Thomson LE, et al. Ranolazine Improves Angina in Women with Evidence of Myocardial Ischemia but No Obstructive Coronary Artery Disease. JACC Cardiovasc Imaging 2011; 4:514.

Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC Fuidelines on the Management of Stable Coronary Artery Disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology. Eur Heart J 2013; 34:2949.

Continue Reading